1. Home
  2. DNLI vs PAR Comparison

DNLI vs PAR Comparison

Compare DNLI & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • PAR
  • Stock Information
  • Founded
  • DNLI 2013
  • PAR 1968
  • Country
  • DNLI United States
  • PAR United States
  • Employees
  • DNLI N/A
  • PAR N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • PAR Office Equipment/Supplies/Services
  • Sector
  • DNLI Health Care
  • PAR Miscellaneous
  • Exchange
  • DNLI Nasdaq
  • PAR Nasdaq
  • Market Cap
  • DNLI 2.1B
  • PAR 2.4B
  • IPO Year
  • DNLI 2017
  • PAR N/A
  • Fundamental
  • Price
  • DNLI $14.19
  • PAR $44.01
  • Analyst Decision
  • DNLI Strong Buy
  • PAR Strong Buy
  • Analyst Count
  • DNLI 16
  • PAR 7
  • Target Price
  • DNLI $33.62
  • PAR $78.43
  • AVG Volume (30 Days)
  • DNLI 2.0M
  • PAR 862.9K
  • Earning Date
  • DNLI 11-05-2025
  • PAR 11-07-2025
  • Dividend Yield
  • DNLI N/A
  • PAR N/A
  • EPS Growth
  • DNLI N/A
  • PAR N/A
  • EPS
  • DNLI N/A
  • PAR N/A
  • Revenue
  • DNLI N/A
  • PAR $418,022,000.00
  • Revenue This Year
  • DNLI N/A
  • PAR $28.96
  • Revenue Next Year
  • DNLI $802.87
  • PAR $14.59
  • P/E Ratio
  • DNLI N/A
  • PAR N/A
  • Revenue Growth
  • DNLI N/A
  • PAR 45.74
  • 52 Week Low
  • DNLI $10.57
  • PAR $43.95
  • 52 Week High
  • DNLI $33.33
  • PAR $82.24
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 41.95
  • PAR 25.07
  • Support Level
  • DNLI $14.63
  • PAR $45.25
  • Resistance Level
  • DNLI $15.69
  • PAR $49.67
  • Average True Range (ATR)
  • DNLI 0.68
  • PAR 1.73
  • MACD
  • DNLI -0.14
  • PAR -0.15
  • Stochastic Oscillator
  • DNLI 0.99
  • PAR 0.57

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

Share on Social Networks: